Effectiveness and tolerability of ezetimibe co-administered with statins versus statin dose-doubling in high-risk patients with persistent hyperlipidemia: The EZE(STAT)2 trial

INTRODUCTION: When a standard dose of statins fails to achieve lipid control in patients at high risk for coronary artery disease (CAD), increasing the statin dosage or co-administration of additional agents is recommended. The aim of this study was to compare the safety and lipid-lowering efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Shekhar Pandey, A., Bissonnette, Stéphane, Boukas, Stella, Rampakakis, Emmanouil, Sampalis, John S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2011
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258811/
https://www.ncbi.nlm.nih.gov/pubmed/22291820
http://dx.doi.org/10.5114/aoms.2011.25550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258811/
https://www.ncbi.nlm.nih.gov/pubmed/22291820
http://dx.doi.org/10.5114/aoms.2011.25550

Ejemplares similares